{"id":7793,"date":"2026-05-12T17:00:00","date_gmt":"2026-05-12T15:00:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab-3\/"},"modified":"2026-05-12T17:00:00","modified_gmt":"2026-05-12T15:00:00","slug":"kommunike-fran-arsstamma-i-nanexa-ab-3","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab-3\/","title":{"rendered":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB"},"content":{"rendered":"
\n

Den 12 maj 2026 h\u00f6lls \u00e5rsst\u00e4mma i Nanexa AB (publ), varvid st\u00e4mman beslutade i enlighet med framlagda f\u00f6rslag. De fullst\u00e4ndiga beslutsf\u00f6rslagen framg\u00e5r av kallelsen till st\u00e4mman.<\/strong><\/p>\n<\/div>\n

\n

Resultat- och balansr\u00e4kning godk\u00e4ndes tillsammans med styrelsens f\u00f6rslag till disposition av bolagets resultat. Styrelsen och VD beviljades ansvarsfrihet f\u00f6r r\u00e4kenskaps\u00e5ret 2025.<\/p>\n

Till styrelseledam\u00f6ter omvaldes G\u00f6ran Ando, Richard Davis, Jakob Dynnes Hansen, Birgit Stattin Norinder och Hanna Tilus. G\u00f6ran Ando omvaldes till styrelseordf\u00f6rande.<\/p>\n

St\u00e4mman beslutade om arvoden till styrelsen i enlighet med valberedningens f\u00f6rslag enligt f\u00f6ljande:<\/p>\n

Styrelsens ordf\u00f6rande erh\u00e5ller ett arvode om 260 000 kronor och \u00f6vriga ledam\u00f6ter, som inte \u00e4r anst\u00e4llda av bolaget, erh\u00e5ller ett arvode om 130 000 kronor. Vidare utg\u00e5r ett arvode till revisionsutskottets ordf\u00f6rande om 100 000 kronor och till \u00f6vriga ledam\u00f6ter i revisionsutskottet ett arvode om 50 000 kronor.<\/p>\n

Till revisor uts\u00e5gs \u00d6hrlings PricewaterhouseCoopers AB. Niclas Bergenmo kommer att forts\u00e4tta i rollen som huvudansvarig revisor.<\/p>\n

Valberedningens f\u00f6rslag till beslut om inr\u00e4ttande av valberedning och valberedningsinstruktion godk\u00e4ndes.<\/p>\n

St\u00e4mman beslutade \u00e4ven att anta styrelsens f\u00f6rslag om bemyndiganden f\u00f6r styrelsen att besluta om f\u00f6retr\u00e4desemission samt riktad emission.<\/p>\n<\/div>\n

\n

F\u00f6r mer information kontakta:<\/strong><\/p>\n

\n

David Westberg \u2013 vd, Nanexa AB (publ)\u00a0
Telefon: 0709-42 83 03
E-post:\u00a0david.westberg@nanexa.se<\/a>
www.nanexa.com<\/a><\/p>\n

Bolagets Certified Adviser \u00e4r Tapper Partners AB.<\/p>\n<\/div>\n

\n

Om Nanexa AB (publ)<\/strong><\/p>\n

\n

Nanexa introducerar kontroll, precision och m\u00e5ngsidighet till l\u00e4kemedelsformuleringar med hj\u00e4lp av ALD-teknik (Atomic Layer Deposition). F\u00f6retagets patenterade PharmaShell\u00ae-plattform \u00e4r ett unikt drug delivery-system som m\u00f6jligg\u00f6r h\u00f6g drug load vilket ger l\u00e5g injektionsvolym och skapar en ny generation formuleringar, s\u00e5 kallade \u201dsuper generics\u201d som ger st\u00f6rre bekv\u00e4mlighet och minskar kostnaderna vid behandling av allehanda sjukdomstillst\u00e5nd som metabola sjukdomar, t ex typ 2-diabetes och obesitas, hematologi\/onkologi, hj\u00e4rt-k\u00e4rlsjukdomar, psykiatri och m\u00e5nga andra.
Nanexa utvecklar egna l\u00e4kemedelsprodukter och har dessutom samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland det senaste licens- och optionsavtalet med Moderna.<\/p>\n

Nanexas aktie \u00e4r noterad p\u00e5 Nasdaq First North Growth Market i Stockholm (NANEXA).<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Den 12 maj 2026 h\u00f6lls \u00e5rsst\u00e4mma i Nanexa AB (publ), varvid st\u00e4mman beslutade i enlighet med framlagda f\u00f6rslag. De fullst\u00e4ndiga beslutsf\u00f6rslagen framg\u00e5r av kallelsen till st\u00e4mman.<\/p>\n","protected":false},"template":"","class_list":["post-7793","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-ci-gm_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-regulatory-listing_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-gm-info_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nKommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/sv\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab-3\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Den 12 maj 2026 h\u00f6lls \u00e5rsst\u00e4mma i Nanexa AB (publ), varvid st\u00e4mman beslutade i enlighet med framlagda f\u00f6rslag. De fullst\u00e4ndiga beslutsf\u00f6rslagen framg\u00e5r av kallelsen till st\u00e4mman.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/sv\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-ab-3\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-ab-3\\\/\",\"name\":\"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2026-05-12T15:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-ab-3\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-ab-3\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-ab-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/sv\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab-3\/","og_locale":"sv_SE","og_type":"article","og_title":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB - Nanexa AB","og_description":"Den 12 maj 2026 h\u00f6lls \u00e5rsst\u00e4mma i Nanexa AB (publ), varvid st\u00e4mman beslutade i enlighet med framlagda f\u00f6rslag. De fullst\u00e4ndiga beslutsf\u00f6rslagen framg\u00e5r av kallelsen till st\u00e4mman.","og_url":"https:\/\/nanexa.com\/sv\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab-3\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/sv\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab-3\/","url":"https:\/\/nanexa.com\/sv\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab-3\/","name":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2026-05-12T15:00:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/sv\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab-3\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/sv\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab-3\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/sv\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/7793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=7793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}